Group items matching

in title, tags, annotations or url

Experience unparalleled cardiac care at Kailash Deepak Hospital, East Delhi's foremost destination for heart health. Our commitment to excellence makes us the best heart hospital in East Delhi. With a team of top cardiologists and cutting-edge technology, we provide comprehensive cardiology services tailored to your needs. Trust us for compassionate care and superior outcomes in managing all cardiac conditions.

Managing diabetes revolves around making mindful food choices. Ms. Veena Kumari, a seasoned Consultant Dietitian at Kailash Deepak Hospital, underscores the pivotal role of diet in diabetes management.

Uncover the warning signs of thyroid disorders in men and provide insights from Dr. Ashish Saini, Consultant Endocrinologist at Kailash Deepak Hospital.

Digital marketing involves promoting products and services using diverse digital arena such as laptops, smart phones, tablets, and other digital touch points to reach customers at the right time through their preferred medium. Pharmaceutical organizations too are indulging in digital platform for marketing of their numerous products.

India is in great need of developing a strong base for conducting medical and clinical research in the country. Medical research in India is still at large limited to some apex medical institutes and central laboratories.

US-based Spectrum Pharmaceuticals has announced that its new drug application (NDA) for Beleodaq has been accepted for filing by the FDA

Otsuka and Lundbeck has received approval from Health Canada to use its intramuscular (IM) once-monthly injectable formulation 'Abilify Maintena' for the maintenance treatment of schizophrenia in stabilized adult patients.

Aegis Therapeutics has been awarded its first patent for oral delivery of nucleotide analog based drugs based upon The company's patented Intravail transmucosal absorption enhancer technology

US-based BioMarin Pharmaceutical has selected a new drug development candidate, BMN 250, for the treatment of Sanfilippo B syndrome or Mucopolysaccharidosis type IIIB (MPS IIIB).

Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has expanded its relationship by entering into a master clinical trial agreement with GRU Cancer Center at Georgia Regents University to conduct four Phase I/II clinical trials.

US-based developer of new immunotherapeutics, including a portfolio of checkpoint modulators, anti-cancer vaccines and adjuvants, Agenus has completed the acquisition of Switzerland-based biopharmaceutical firm 4-Antibody.

Celerion, a leader in early clinical research, is pleased to announce the expansion of clinical operations to South Korea.

US-based Edison Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for its lead drug EPI-743 to treat patients with Friedreich's ataxia.